| Dr Ramandeep Dulai, MD | |
|
4040 Fairfax Dr Ste 801, Arlington, VA 22203-1765 | |
| (571) 970-6050 | |
| (571) 970-6352 |
| Full Name | Dr Ramandeep Dulai |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 4040 Fairfax Dr Ste 801, Arlington, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629046495 | NPI | - | NPPES |
| 010210917 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101055520 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Womens Care Llc | 4880582741 | 248 |
News Archive
PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
At a U.N. Population Fund (UNFPA) meeting in Addis Ababa, Ethiopia, "[h]ealth ministers from around the world have agreed that swift action must be taken to reduce the number of women dying during pregnancy and childbirth," the BBC reports. While there appeared to be some agreement "that family planning was the most cost-effective way of [tackling] the problem ... no unanimous declaration was adopted at the Addis Ababa talks," according to the news service (10/26).
Recognizing growing concerns about novel coronavirus (COVID-19), CreakyJoints, a Global Healthy Living Foundation digital patient community, developed educational resources for their chronic disease patient community, many of whom are immunocompromised.
Physicians tend to share patients with colleagues who have similar personal traits and practice styles, and there is substantial variation in physician network characteristics across geographic areas, according to a study in the July 18 issue of JAMA.
› Verified 3 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
At a U.N. Population Fund (UNFPA) meeting in Addis Ababa, Ethiopia, "[h]ealth ministers from around the world have agreed that swift action must be taken to reduce the number of women dying during pregnancy and childbirth," the BBC reports. While there appeared to be some agreement "that family planning was the most cost-effective way of [tackling] the problem ... no unanimous declaration was adopted at the Addis Ababa talks," according to the news service (10/26).
Recognizing growing concerns about novel coronavirus (COVID-19), CreakyJoints, a Global Healthy Living Foundation digital patient community, developed educational resources for their chronic disease patient community, many of whom are immunocompromised.
Physicians tend to share patients with colleagues who have similar personal traits and practice styles, and there is substantial variation in physician network characteristics across geographic areas, according to a study in the July 18 issue of JAMA.
› Verified 3 days ago
| Entity Name | Capital Womens Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679534069 PECOS PAC ID: 4880582741 Enrollment ID: O20040315000188 |
News Archive
PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
At a U.N. Population Fund (UNFPA) meeting in Addis Ababa, Ethiopia, "[h]ealth ministers from around the world have agreed that swift action must be taken to reduce the number of women dying during pregnancy and childbirth," the BBC reports. While there appeared to be some agreement "that family planning was the most cost-effective way of [tackling] the problem ... no unanimous declaration was adopted at the Addis Ababa talks," according to the news service (10/26).
Recognizing growing concerns about novel coronavirus (COVID-19), CreakyJoints, a Global Healthy Living Foundation digital patient community, developed educational resources for their chronic disease patient community, many of whom are immunocompromised.
Physicians tend to share patients with colleagues who have similar personal traits and practice styles, and there is substantial variation in physician network characteristics across geographic areas, according to a study in the July 18 issue of JAMA.
› Verified 3 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298 |
News Archive
PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
At a U.N. Population Fund (UNFPA) meeting in Addis Ababa, Ethiopia, "[h]ealth ministers from around the world have agreed that swift action must be taken to reduce the number of women dying during pregnancy and childbirth," the BBC reports. While there appeared to be some agreement "that family planning was the most cost-effective way of [tackling] the problem ... no unanimous declaration was adopted at the Addis Ababa talks," according to the news service (10/26).
Recognizing growing concerns about novel coronavirus (COVID-19), CreakyJoints, a Global Healthy Living Foundation digital patient community, developed educational resources for their chronic disease patient community, many of whom are immunocompromised.
Physicians tend to share patients with colleagues who have similar personal traits and practice styles, and there is substantial variation in physician network characteristics across geographic areas, according to a study in the July 18 issue of JAMA.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ramandeep Dulai, MD 8110 Maple Lawn Blvd Ste 235, Fulton, MD 20759-2694 Ph: (301) 340-8339 | Dr Ramandeep Dulai, MD 4040 Fairfax Dr Ste 801, Arlington, VA 22203-1765 Ph: (571) 970-6050 |
News Archive
PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
At a U.N. Population Fund (UNFPA) meeting in Addis Ababa, Ethiopia, "[h]ealth ministers from around the world have agreed that swift action must be taken to reduce the number of women dying during pregnancy and childbirth," the BBC reports. While there appeared to be some agreement "that family planning was the most cost-effective way of [tackling] the problem ... no unanimous declaration was adopted at the Addis Ababa talks," according to the news service (10/26).
Recognizing growing concerns about novel coronavirus (COVID-19), CreakyJoints, a Global Healthy Living Foundation digital patient community, developed educational resources for their chronic disease patient community, many of whom are immunocompromised.
Physicians tend to share patients with colleagues who have similar personal traits and practice styles, and there is substantial variation in physician network characteristics across geographic areas, according to a study in the July 18 issue of JAMA.
› Verified 3 days ago
Dr. Luis E. Sanz, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1625 N George Mason Dr, Suite 475, Arlington, VA 22205 Phone: 703-717-4000 Fax: 703-717-4009 | |
Amanda Elaine Rohn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr, Suite 325, Arlington, VA 22205 Phone: 703-717-4600 | |
Saliatou Maikarfi Jordan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4040 Fairfax Dr Ste 801, Arlington, VA 22203 Phone: 571-970-6050 Fax: 571-950-6352 | |
Dr. Jennifer Lynn Kilmer, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1625 N George Mason Dr, Suite 465, Arlington, VA 22205 Phone: 703-717-4050 Fax: 703-717-4057 | |
Jessica Leigh Hardesty, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Arlington, VA 22205 Phone: 703-717-4502 | |
Melanie Polin, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1701 N George Mason Dr, Arlington, VA 22205 Phone: 703-717-4600 | |
Dr. William Albright Burch Iii, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5275 Lee Highway, Suite 101, Arlington, VA 22207 Phone: 703-358-8700 Fax: 703-358-8703 |